Neuroblastoma is one of the most common childhood tumours. We’ve been working hard to develop more effective treatments, and although this is making a difference, we’re still working towards a cure. To achieve this we need to know more about how neuroblastoma starts, and how it resists even the most intensive treatment. This project will help us learn more.
We’re funding this project because in order to find better treatments for neuroblastoma we need to know more about how it starts and how it resists the existing therapies.
This research project on neuroblastoma has been successfully completed. Your donations allow us to fund ground-breaking research that can improve treatments given to children with cancer. Thank you. Your help allows us to continue to find ways to drive up the chances of survival for children with cancer and reduce the toxic side effects that can affect the rest of their lives.
Oncogenic LGR5-mediated Wnt signalling as a target for neuroblastoma therapy
Dr Karim Malik
University of Bristol
Bristol, BS8 1TD
2 September 2013
3 years & 6 months